Report

Pharmacological Rescue of Mutant p53 Conformation and Function

Science  24 Dec 1999:
Vol. 286, Issue 5449, pp. 2507-2510
DOI: 10.1126/science.286.5449.2507

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Compounds that stabilize the DNA binding domain of p53 in the active conformation were identified. These small synthetic molecules not only promoted the stability of wild-type p53 but also allowed mutant p53 to maintain an active conformation. A prototype compound caused the accumulation of conformationally active p53 in cells with mutant p53, enabling it to activate transcription and to slow tumor growth in mice. With further work aimed at improving potency, this class of compounds may be developed into anticancer drugs of broad utility.

  • * To whom correspondence should be addressed. E-mail: Farzan_Rastinejad{at}groton.pfizer.com

View Full Text

Related Content